Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com admin Website Related Posts SPUT’s US$200 Million Uranium Buying Plan Spurs Market Rally June 18, 2025 Market Presentation June 18, 2025 Acquisition of Solar Panel Recycling Technology June 18, 2025